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Hygiene, University Medical Centre of the Johannes Gutenberg University, Mainz, GermanyABSTRACT CD81 is a ubiquitously expressed member of the tetraspanin family. It forms large molecular platforms, so-called
tetraspanin webs that play physiological roles in a variety of cellular functions and are involved in viral and parasite infections. We
have investigated which part of the CD81 molecule is required for the formation of domains in the cell membranes of T-cells and
hepatocytes. Surprisingly, we find that large CD81 platforms assemble via the short extracellular d-domain, independent from a
strong primary partner binding and from weak interactions mediated by palmitoylation. The d-domain is also essential for the
platforms to function during viral entry. We propose that, instead of stable binary interactions, CD81 interactions via the small
d-domain, possibly involving a dimerization step, play the key role in organizing CD81 into large tetraspanin webs and controlling
its function.INTRODUCTIONTetraspanins constitute a family of small, conserved four
transmembrane spanning proteins with 33 members in
humans and mice (1). They form extended networks of
molecular interactions with other surface molecules called
tetraspanin webs or tetraspanin-enriched microdomains
(TEMs or TERMs) by means of their strong tendency to
associate laterally with one another, with integrins, mem-
bers of the Ig superfamily and/or signaling receptors
(2–5). TEMs play a role in an astonishing diverse range of
cellular processes, including cell proliferation, adhesion,
spreading and migration, signal-transduction, endocytic
trafficking, cell-cell fusion, and host-pathogen interactions
(5,6). Due to their involvement in malignancy, the immune
system, and infectious diseases, they emerged as potential
targets in therapeutic strategies (7).
One of the most studied tetraspanins is CD81 (Cluster of
Differentiation 81), also known as 26 kDa cell surface pro-
tein or tetraspanin 28. Initially, functions of CD81 were
discovered in the immune system including B- and T-cell
activation, as target of an antiproliferative antibody (8).
Meanwhile other roles in many different cell types have
been documented, including brain development (9), retinal
pigment epithelium development (10), and fertility (11)
(for review see (1,12)).
Apart from its biological functions, CD81 is clinically
significant acting as an entry factor for infections with the
hepatitis C virus (HCV) (13), the malaria PlasmodiumSubmitted November 20, 2013, and accepted for publication May 20, 2014.
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0006-3495/14/07/0100/14 $2.00parasite (14), and Listeria monocytogenes (15). More-
over, TEMs provide entry and/or exit platforms for human
papilloma virus (HPV) and human immunodeficiency virus
(16–18) and other pathogens (19,20).
It is still under debate how CD81 or tetraspanins in gen-
eral form tetraspanin webs. Complexes found in immuno-
precipitates after lysing cells with detergents of different
strength have led to a hierarchical classification of inter-
actions involved in tetraspanin web formation. Interactions
between tetraspanins and their nontetraspanin partners that
are resistant to Triton X-100 and digitonin are referred
to as primary complexes (7,21). Under these conditions
tetraspanin-tetraspanin interactions are disrupted but can
be maintained using milder detergents such as Brij 97 or
CHAPS. Interactions preserved only under mild solubili-
zation conditions are thought to be weaker, less defined
second-level interactions (1,22) that presumably lead to
the association of primary complexes forming a large tetra-
spanin network. Interactions are further stabilized by protein
palmitoylation (7,23,24). For instance, palmitoylation of
the tetraspanin CD81 promotes its association with the tet-
raspanin CD9 and one of its major primary binding partners
EWI-2 from the Ig superfamily (25,26). Accordingly, a
palmitoylation deficient mutant of the tetraspanin CD151
associates less with CD81 and CD82 (27). Still, it is debated
what mechanism drives the coalescence of such a variety
of different complexes/molecules into large tetraspanin
webs (5).
To date, the complete three-dimensional structure has
been predicted for only one tetraspanin, CD81 (28). As
in all tetraspanins, a small and a large extracellular loophttp://dx.doi.org/10.1016/j.bpj.2014.05.028
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mains a, b, g, d, and ε) are each flanked by transmembrane
regions (TMs), TM1/TM2 and TM3/TM4, respectively. The
TMs are closely packed and in continuity of TM3 and TM4
two extracellular antiparallel alpha-helices (a and ε) form
the central stalk of the LEL conferring a compact rod-
shaped structure to the molecule, with only the short d-
domain exposed at the side of the extracellular terminus.
The short intracellular segments harbor palmitoylation sites,
two at each of the N- and C-terminal tails and two at the
linker between TM2 and TM3. The LEL is structurally sub-
divided into a conserved and a nonconserved section, the so-
called constant (a, b, and ε) and variable region (g and d),
respectively (28).
Different conformations of the LEL are observed in
hexagonal and monoclinic crystals and in solution sug-
gesting that conformational flexibility of this region plays
a key role in tetraspanin web assembly and function
(29–31). This is in line with the findings that the variable
region is crucial for tetraspanin protein-protein interactions
and presumably defines the diverse tetraspanin classes
(3,32,33).
Here, we have examined how the lateral organization of
CD81 in the plasma membrane depends on CD81 protein
domains and identified a small part of the variable region,
the d-domain, to organize CD81 into tetraspanin platforms,
a mechanism supported but in principle independent from
primary complexes.MATERIALS AND METHODS
Cloning
From a cDNA library we obtained by polymerase chain reaction (PCR) the
sequences for CD81 (NM_004356.3), EWI-2 (NM_052868.4), and CD9
(NM_001769.3), which were subcloned using the pGEM-T easy vector
system (catalogue No. A1360, Promega, Madison, WI). All constructs
were expressed using the expression vector pEGFP-C1 (catalogue No.
6084-1, clontech, Mountain View, CA) backbone, lacking EGFP. Via
fusion PCR, CD81 was fused directly to the N-terminus of monomeric-
enhanced GFP (carrying the mutation A207K, which corresponds to
A206K described in (34)) with a stop codon and inserted via the NheI/
KpnI sites. Substitution and deletion constructs of CD81 were produced
by fusion PCR and inserted using a C-terminal Kpn2I restriction site within
the CD81 sequence, via the NheI/Kpn2I sites. In cases the modification
was downstream of the Kpn2I site, PCR was performed over the entire
CD81-mGFP construct and the NheI/KpnI sites were used. The following
constructs were produced according to this procedure. C/A, substitution of
the juxtamembrane cysteines by alanines in the positions 6, 9, 80, 89, 227,
and 228; Dab lacking aa 115–155; Dg, lacking aa 156–174; Dgd. lacking
aa156–190; Dd, lacking aa 176–186. Following the same procedure, a
CD81-mRFP construct was cloned fusing C-terminally to CD81 mRFP
((35); carrying two silent mutations for introducing a restriction site)
with a stop codon.
The C-terminus of EWI-2 or CD9 was fused directly to the N-terminus of
a C-terminally myc-tagged mRFP (myc sequence; GAACAAAAACT-
TATTTCTGAAGAAGATCTG followed by a stop codon) via PCR and
the EWI-2-mRFP-myc or CD9-mRFP-myc sequence was inserted into
pEGFP-C1 via the AgeI/KpnI sites (for EWI-2) or NheI/KpnI (for CD9).Cell culture
Jurkat E6.1 cells and HepG2 cells were cultured essentially as described
previously (36). For transfections, 60 mg plasmid (in double transfections
30 mg plasmid of each construct) was added per electroporation cuvette.
Electroporation was performed with a Gene pulser Xcell electroporation
system (Bio-Rad, Hercules, CA). Jurkat T cells and HepG2 cells were
used for experiments 2 days and 1 day after transfection, respectively.Antibodies
Mousemonoclonal antibodieswere used for humanCD81 (catalogueNo. 16-
0819, eBioscience, San Diego, CA) and GFP (clone 3E6, catalogue No.
A11120, Invitrogen, Carlsbad, CA). For staining of pseudovirions (PsVs)
we used the polyclonal antibody K75 raised against the L1 protein of the
PsVs (16). As secondary antibodies, we used AlexaFluor594-labeled donkey
antimouse IgG (HþL) (catalogue No. A21203, Invitrogen), AlexaFluor546-
labeled donkey antirabbit IgG (catalogue No. A10040, Invitrogen), or Alexa-
Fluor488 donkey antimouse IgG (HþL) (catalogueNo. A21202, Invitrogen).Epifluorescence microscopy
For imaging, we used an Olympus IX81 microscope equipped with a 60 
1.49 NA Apochromat objective applying a 1.6magnifying lens (Olympus,
Tokyo, Japan) and an EMCCD camera (16  16 mm2 pixel size, ImagEM
C9100-13, Hamamatsu Photonics, Hamamatsu, Japan) with a 2 magni-
fying lens. For illumination, we used a 488 laser (LAS/488/20, Olympus)
or a 150 W Xenon lamp integrated into the MT20E-fluorescence illumina-
tion system (Olympus) in combination with the following filter sets: CMR-
U-MTIR-488-HC (Olympus) and F36-500 DAPI HC, F36-525 EGFP HC,
and F36-503 Tritc HC (AHF Analysentechnik, Tuebingen, Germany). All
images are shown applying a linear lookup table at arbitrary scalings.Confocal microscopy
For confocal microscopy we used an Olympus FluorView 1000 microscope
as described previously (37). Fluorescence recovery after photobleaching
measurements were essentially performed and analyzed as described
((37); pixel size was adjusted to 207 nm; for recording the 488 nm laser
line and for bleaching the 488 and 405 nm laser lines were used). Other-
wise, pixel size was adjusted to 103 nm and DAPI (blue), GFP (green),
and Alexa546 (red) were excited at 405, 488, and 543 nm, respectively.
Fixed cells were mounted on microscopy slides with 15 ml mounting
medium with antifade (catalogue No. P10144, Invitrogen) and cured for
24 h at room temperature (RT). Transfected cells were identified in the
green channel, followed by taking at different axial positions optical sec-
tions in the blue, green, red, and bright-field channels. For live cell imaging
at RT in Ringer solution (130 mM NaCl, 4 mM KCl, 1 mM CaCl2, 1 mM
MgCl2, 48 mM D(þ)glucose, 10 mM HEPES, pH 7.4) areas were selected
in the bright-field mode, followed by taking a bright-field and fluorescence
images.Pearson correlation coefficient
The Pearson correlation coefficient (PCC) quantifies the degree of colocal-
ization between two images (38). In principle, its value ranges from 1 (per-
fect overlap) through 0 (no relation) to 1 (perfectly anticorrelating
images). Using the program ImageJ we employed the plugin Align slice
(Gabriel Landini, University of Birmingham) for manual alignment of
images from different channels allowing corrections of lateral shifts in
the x and y directions that occasionally occurred during imaging. The
PCC was calculated for the aligned images using the plugin Colocaliza-
tion_Indices (Kouichi Nakamura, Kyoto University).Biophysical Journal 107(1) 100–113
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An image region defined by a region of interest (ROI) was duplicated
yielding the reference image. Using the ImageJ plugin Align slice, the
ROI was repeatedly shifted by 1 pixel in one direction subsequently
duplicating the respective region. The PCCs between the reference and
the duplicates from the shifted images were then calculated using the
Colocalization_Indices plugin and the values (starting with 1) were plotted
against the pixel shift. For analysis of stimulated emission depletion
(STED) micrographs, we also used the GDSC stack correlation analyzer
plugin and always increased Pixel intensity by one to avoid zero values
that cannot be processed. For each independent experiment, values from
different cell membranes were averaged and a curve was fitted (y ¼ 1 –
(a  x)/(b þ x)) yielding the 50% decay value. For STED microscopy, cor-
relation was performed on three different ROIs for each membrane sheet;
the curves were averaged and fitted using a simple exponential decay func-
tion, yielding the 50% decay value for the respective membrane.Immunostaining for CD81
Membrane sheets were generated from transfected cells in ice-cold sonicat-
ion buffer (120 mM potassium glutamate, 20 mM potassium acetate,
10 mM EGTA, 20 mM HEPES, pH 7.2) as described previously (37) and
fixed directly with 4% paraformaldehyde (PFA) in phosphate buffered sa-
line (PBS) (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, pH 7.4) for
30 min at RT. PFA was quenched for 30 min at RT with 50 mM NH4Cl
in PBS, followed by 3 washes of 10 min with PBS. Membrane sheets
were incubated with the first antibody (diluted 1:100 in 3% bovine serum
albumin (BSA)-PBS) for 1 h at RT followed by 3 PBS washing steps of
10 min. Incubation with the secondary antibody (AlexaFluor594 labeled
donkey anti-mouse diluted 1:200 in 3% BSA-PBS) at RT lasted 1 h for
HepG2 membrane sheets and overnight for Jurkat T cell membrane sheets.
Afterward, the coverslips were washed 3 times with PBS for 10 min and
imaged in PBS containing 1-(4-tri-methyl-ammonium-phenyl)-6-phenyl-
1,3,5-hexatriene p-toluene-sulfonate (TMA-DPH, catalogue No. T-204,
Invitrogen) for visualization of membranes. In the green channel, exposure
times for recording of Jurkat and HepG2 membrane sheets were 100 ms and
1 s, respectively. In the red channel, recording times were 100 and 500 ms
for Jurkat and HepG2 membrane sheets, respectively. Background cor-
rected intensities were determined for the green and red channels of
individual membrane sheets using ImageJ. The PCC between the images
from the red and the green channels was determined as described pre-
viously. Corrections for lateral shifts were performed manually using the
Align slice plugin referring to at least 4 to 5 different structures apparent
in both channels or to 100 nm Tetraspeck beads (TetraSpeck Microspheres,
catalogue No.T-7279, Invitrogen) for Jurkat and HepG2 membrane sheets,
respectively.STED microscopy sample preparation
and imaging
Membrane sheets were generated from HepG2 cells transfected and fixed
as described previously. After quenching for 20–30 min with 50 mM
NH4Cl in PBS, membranes were washed three times with PBS and blocked
for 1 h at RT in 3% BSA-PBS. Membranes were then incubated with anti-
GFP antibody, diluted 1:100 in 1% BSA-PBS overnight at 4C. After 4
washes with PBS, incubation with the secondary antibody (Alexa488
labeled-donkey antimouse), diluted 1:100 in 1% BSA-PBS, was performed
for 2 h at RT. After 3 washes with PBS, coverslips were mounted on micro-
scopy slides and embedded as described for confocal microscopy samples.
Samples were sealed with clear nail polish and stored at 4C.
For imaging, we used a TCS-SP8 gated-STED microscope (Leica,
Mannheim, Germany) at the Light Microscopy Facility (LMF) at the
German Centre for Neurodegenerative Diseases (DZNE) in Bonn. First,Biophysical Journal 107(1) 100–113confocal images were taken into the red channel to detect EWI-2-RFP
and into the green channel to measure CD81-GFP intensity. STED images
were recorded at 200 Hz, 40% STED beam intensity, gating between 1 and
6.5 ns and Pixel sizes were close to 20 nm. Analyzed STED micrographs
were composed of 6 averaged frames.Coclustering assay
From cotransfected cells, expressing either CD81-RFP and CD81-GFP or a
GFP-labeled CD81 variant, EWI-2-RFP or CD9-RFP and GFP-labeled
CD81 or CD81 variants membrane sheets were generated, fixed, quenched,
and washed as described previously. Imaging was performed in PBS con-
taining TMA-DPH, after adding 100 nm Tetraspeck beads for the correction
of lateral shifts that occasionally occurred between filter changes. Green,
red (which tended to yield less clustered patterns), and blue channels
were recorded in the epifluorescence mode of the microscope. Images
were analyzed using the program ImageJ. First, an image stack including
all three channels was created and, if necessary, corrected for lateral shifts
(referring to Tetraspeck beads) using the Align Slice plugin of ImageJ.
A ROI was then placed on the basal membrane for generating duplicates
from the green and red channels, which were used for calculating the
PCC using the Colocalization Indices plugin of ImageJ. In experiments
involving EWI-2-RFP, we also performed autocorrelation analysis on the
green channel.Total internal reflection fluorescence (TIRF)
microscopy
Jurkat cells were cultured in suspension for 2 days after transfection and
harvested through 3 min of centrifugation at 1000 rpm in an Eppendorf
(Hamburg, Germany) centrifuge 5810. The cell pellet was resuspended in
Ringer solution and aliquots were plated into 6-well plates at a concen-
tration of ~1.5  106 cells/well, containing poly-L-lysine coated glass
coverslips with a diameter of 25 mm. Cells adhered in the cell incubator
for 20 min and were imaged within the following 20 min. Imaging was
performed in the TIRF mode of the microscope, which selectively excites
fluorescence in a thin layer spanning only a few 100 nm at the glass-water
interface, including the basal membrane of the adhered cells. Movies were
recorded at 2 Hz for ~15 s. Images were analyzed using the program
ImageJ, calculating the PCC between two successive frames separated by
a time interval of 0.5 s. Values obtained from one movie were averaged.
For each independent experiment the values obtained from all movies
were averaged.Pseudovirion-induced endocytosis
Jurkat cells were transfected with either CD81-GFP or CD81-Dd-GFP and
cultured for 2 days in suspension. 106 cells were pelleted for 3 min at
1000 rpm in an Eppendorf centrifuge 5810, resuspended in 5 ml prewarmed
medium, and transferred into a 25 cm2 flask. Sulforhodamine101 (catalogue
No. s7635, Sigma-Aldrich, St. Louis, MO) was added to a final concentra-
tion of 20 mM and, where required, 2 ml of PsVs were added (corresponding
to 0.42 mg total protein or 0.2 mg of the major capsid protein L1 of HPV;
PsVs were prepared as previously described (39)). The mixture was incu-
bated for 10 min in the cell incubator with gentle agitation from time to
time to avoid cell sedimentation. Cells were then centrifuged for 3 min at
800 rpm (using an Allegra X-15R centrifuge from Beckman Coulter,
Brea, CA), the pellet was resuspended in 1 ml prewarmed Ringer solution
and 0.5 ml aliquots each were directly plated onto poly-L-lysine coated
glass coverslips. The cells were adhered for 20 min in the cell incubator
and directly fixed for 30 min with 4% PFA in PBS after membrane sheet
generation. To correct for potential lateral shifts that occur occasionally
during imaging, the samples were supplemented with 100 nm Tetraspeck
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using epifluorescence microscopy in the green, red, and blue channels visu-
alizing the CD81/CD81-Dd distribution, endosomes or the plasma mem-
brane, respectively. For analysis, we manually determined the number of
endosomes (as visualized by the fluid phase marker in the red channel)
per membrane sheet colocalizing with a CD81/CD81-Dd cluster in the
green channel.
In a second set of experiments, 5,105 transfected cells were incubated in
the absence of Sulforhodamine in 1 ml prewarmed medium adding 5 ml
of PsVs. The suspension was incubated for 1 h at 37C in a rotating
Eppendorf tube. Cells were adhered and fixed as previously mentioned
before they were permeabilized for 2 min in 0.2% Triton X-100 in PBS.
After a PBS wash, cells were blocked for 30 min with 1% BSA-PBS. Incu-
bation with the first antibody K75, diluted 1:1000 in 1% BSA-PBS, was
then performed for 1 h at 37C. After one wash in PBS and another wash
in 1% BSA-PBS, the secondary antibody was applied (Alexa546 donkey
anti-rabbit IgG, diluted 1:300) in 1% BSA-PBS containing Hoechst dye
(diluted 1:10,000) for 1 h at 37C. After two washes in PBS, cells were
embedded for confocal microscopy as described above.RESULTS
To investigate CD81 membrane organization, we used un-
roofed cells (i.e., plasma membrane sheets). For this deter-
gent-free preparation, a 100 ms ultrasound pulse generates
essentially pure basal plasma membranes through mechani-
cal shearing forces (40). Because the membranes remain
attached to the glass coverslip, they constitute flat objects
on which the distribution of plasmalemmal components
can be imaged by epifluorescence microscopy with high
sensitivity. Previous work showed that the morphology of
the inner membrane leaflet is retained on immediately fixed
membrane sheets (41) and that diffusion of a membrane
protein in freshly prepared membranes is the same as in
intact cells (42). This suggests that plasma membrane sheets
are a suitable and convenient preparation for studying selec-
tively proteins expressed on the cell surface.
First, we examined how the distribution of CD81 in the
cell membrane depends on its concentration. We expressed
GFP-labeled CD81 (for C-terminal tagging of CD81 by GFP
see also (43)) in cells endogenously lacking (HepG2 cells) or
expressing CD81 (Jurkat T cells). Membrane sheets were
fixed immediately and also immunostained for CD81. In
the green channel, we recorded overexpressed CD81-GFP
and in the red channel immunostaining of overexpressed
CD81 and, in the case of Jurkat T cells, also endogenous
CD81. Over the entire concentration range CD81 was con-
centrated in spotty structures, though the cluster pattern
was potentially not completely resolved due to diffraction-
limited imaging. Moreover, as shown in Fig. S1, in the
Supporting Material: i), HepG2 cells lack, as expected,
endogenous CD81; ii), in Jurkat T cells overexpression
in most membranes hardly doubled total CD81; and iii),
overexpressed and endogenous CD81 do not form distinct
patterns.
For a more detailed analysis we turned to superresolution
light microscopy on HepG2 cells, in which the clustering of
expressed CD81 can be studied in the absence of endoge-nous CD81. At lower concentrations up to densities of
40 clusters per mm2, cluster density was linearly related to
CD81 concentration: ~twofold more clusters formed upon
doubling the concentration (see inset in Fig. 1 C). Upon a
further increase in CD81, cluster density rose less, almost
certainly because individual clusters can no longer be
resolved properly (even at superresolution) and their num-
ber is underestimated (Fig. 1; see membrane sheets #3 and
#4 at STED microscopy resolution). From this data, we
conclude that more CD81 molecules primarily form more
clusters rather than increasing their size or causing a more
uniform distribution of molecules.
Next, we aimed for identifying the CD81 protein do-
main(s) or feature(s) necessary for targeting the molecule
into CD81 microdomains. In Jurkat T cells, we overex-
pressed CD81-RFP together with CD81-GFP or GFP-fused
to a CD81 variant and analyzed whether the red and green
constructs are enriched in the same domains (Fig. 2). For
quantification of the similarity between the green and the
red channels we calculated the PCC, which is independent
from offsets and absolute intensities in the two channels,
weighting the departure from the mean (38).
As suggested by a high PCC (on average 0.6; Fig. S2),
CD81-RFP and CD81-GFP were located in the same
domains, indicating that the targeting mechanism did not
discriminate between the differently labeled constructs
(Fig. 2 A). When all six palmitoylation sites were replaced
by alanines, coenrichment decreased only slightly (Fig. 2
C), suggesting that palmitoylation plays some yet not the
major role. We then deleted almost half of the LEL,
including the a- and b-helical domains, expected to have
a strong impact on the structural orientation of the remain-
ing helices (see Fig. S3 for illustration). However, despite
such dramatic modification of the molecule it was still
capable of forming CD81 domains (Fig. 2 C), indicating
that the previously described dimerization via the ab-inter-
face (29,30,44) is not a prerequisite for domain targeting.
The variable region within the LEL plays the major role
in specific interactions. In fact, deletion of the variable re-
gion and its two flanking cysteines (aa 156–190; (12,29);
also see Fig. S3 for illustration of the deleted domains)
strongly decreased domain targeting (Fig. 2 C). The variable
region contains two alpha-helical domains separated by a
disulfide bridge, referred to as g-domain (158–174, not
including the flanking cysteines) and d-domain (176–189)
(29). A construct lacking the g-domain (D156–174) essen-
tially behaved like wild-type CD81, whereas deletion of
the d-domain (D176–186) diminished domain targeting to
a level indistinguishably from that seen for the construct
lacking the entire variable region (Fig. 2, B and C). This
effect was not caused by incomparable cell surface expres-
sion levels of CD81-GFP and CD81-Dd-GFP (Fig. S4), and
we also verified by confocal microscopy that CD81-Dd-GFP
was not retained more strongly in intracellular structures
(Fig. S5). As an alternative approach to validate the resultBiophysical Journal 107(1) 100–113
FIGURE 1 Elevation of CD81 levels generates
more clusters. CD81-GFP was expressed in HepG2
cells and for gated STED imaging of membrane
sheets, and the signal was enhanced by immuno-
staining for GFP. (A) Confocal micrographs (to
minimize bleaching) for quantification of CD81
expression levels. Shown are four membrane sheets
(see labels #1 to #4) from cells with varying CD81
expression levels applying the fire lookup table at
the same scaling. Immunostaining intensity was
quantified and taken as readout for relative CD81
concentration. (B) Upper panel, sections from
larger STED micrographs, corresponding to the
white squares in A. On each original STED micro-
graph three ROIs (one shown in the lower panel)
were selected for manual cluster counting; aver-
aging all three values yielded the cluster density
obtained from the respective membrane sheet.
Images are shown at the same scaling. (C) Cluster
density plotted against CD81 concentration. Labels
#1 to #4 mark intensity values obtained for the
respective membrane sheets shown in (A). The
inset illustrates the linear relationship between
cluster density and CD81 concentration in the
lower concentration range. Membrane sheets were
collected from three independent experiments
(8–13 membrane sheets per experiment). To see
this figure in color, go online.
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tation experiments after cell solubilization with CHAPS.
CD81-GFP pulled down endogenous CD81, as expected,
whereas CD81-Dd-GFP was less efficient (Fig. S6). This
indicates that CD81-Dd-GFP and CD81 are still interacting,
presumably via their a/b-domains, albeit in steady state the
number of complexes is reduced as CD81-Dd-GFP is less
enriched in CD81 microdomains (Fig. 2) due to diminished
binding either to other CD81 molecules (forming dimers by
a mechanism that in this case would be independent from
the described a/b-interface dimerization) or to other TEM
components. Alternatively, the capability to form dimers
is reduced and dimer formation is a prerequisite for TEM
targeting.Biophysical Journal 107(1) 100–113The d-domain-dependent CD81 targeting was also ob-
served in HepG2 cells (Fig. S7). Furthermore, CD81-Dd
was not uniformly distributed but formed separate clusters
in both cell types. From these data we conclude that
correct targeting of CD81 into CD81 domains requires the
d-domain, whereas other regions of the LEL and palmitoy-
lation play a less prominent role, at least when analyzing the
static distribution of molecules in the membrane.
Large tetraspanin webs or TEMs are circular in shape
and relatively stable in position (45,46). In case CD81 do-
mains represent large tetraspanin webs or TEMs, they
should be less dynamic than putative non-TEM domains
formed by CD81-Dd. For clarification, we performed fluo-
rescence recovery after photobleaching measurements in
FIGURE 2 The d-domain of the LEL is required for targeting of the CD81 molecule into CD81-enriched domains. Membrane sheets from Jurkat T cells
co-overexpressing CD81-RFP along with CD81-GFP (A) or CD81-Dd-GFP (B). Images were recorded in the red (RFP), green (GFP), and blue (TMA-DPH, a
general membrane stain) channels. RFP- and GFP-labeled CD81 are enriched in the same domains, whereas deletion of the d-domain strongly decreases the
overlap between full length CD81-RFP and CD81-Dd-GFP (for comparison see dotted circlesmarking identical locations). (C) PCC between CD81-RFP and
CD81-GFP or a GFP-labeled CD81 variant. Pictograms show the respective GFP-labeled constructs whose lateral distribution was compared to CD81-RFP;
please note that the pictograms are schemes not reflecting the real size and orientation of the domains; for the relation between the pictogram and the pre-
dicted 3D structure see Fig. S3, which also illustrates the size of the deleted molecule portions on a realistic scale. From top: CD81; C/A, with all cysteine
palmitoylation sites substituted by alanines; Dab, Dgd, Dg, and Dd, deletion of the respective domains of the LEL (large extracellular loop). SEL, small
extracellular loop; red solid circles with acyl chains indicate cysteine palmitoylation sites. t1–t4 indicate transmembrane regions. Values are given as
means 5 SE (n ¼ 3–10 independent experiments; for each experiment values from 5 to 22 membrane sheets were averaged and normalized to control
(CD81-GFP)). To see this figure in color, go online.
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lateral diffusion coefficient of 0.03 mm2/s. Compared to
previously published values in polarized and nonpolarized
HepG2 cells, in which 0.07 and 0.11 mm2/s have been
determined (47), respectively, the lower value is expected
as in Jurkat T cells CD81 forms larger clusters (see below).
Consistent with this view, we find a strongly increased
diffusion coefficient of CD81-Dd (Fig. S8). To study the
stability of the domains we further examined CD81 and
CD81-Dd cluster dynamics using TIRF microscopy. As
shown in Fig. 3, most CD81 clusters were stable over sec-
onds, whereas CD81-Dd clusters translocated and/or disas-
sembled. When the entire variable region was deleted,
dynamics of platforms did not increase further, and deletion
of the g-domain alone showed a cluster pattern comparable
to wild-type CD81 (see Fig. 3 E). The d-domain-dependent
effect on stability correlates well with the results from
targeting analysis, suggesting that CD81 is organized inlarger and stable molecular platforms only in the presence
of the d-domain.
The primary binding partner EWI-2 forms stable Triton
X-100 resistant complexes with CD81 (25,48) via interac-
tions involving from EWI-2 the short cytoplasmic tail and
the glycine-zipper motif in the TM, and from CD81 the
TM3 and TM4, with some contributions of the extracellular
domains (49). To clarify whether CD81 and CD81-Dd clus-
ters differ in their capability to incorporate primary binding
partners, we elevated the concentration of EWI-2. As shown
in Fig. 4, in Jurkat T cells EWI-2 and CD81 coenriched
in the same domains, indicating the formation of primary
complexes (Fig. 4, A and C). As for domain targeting of
CD81 (Fig. 2) and domain dynamics (Fig. 3), also for the
coenrichment of CD81 and EWI-2 only the d-domain was
required (Fig. 4 C).
Next, we tested association of CD81 with another tetra-
spanin, CD9. Compared to CD81, overlap with CD9 wasBiophysical Journal 107(1) 100–113
FIGURE 3 Dynamics of CD81 and CD81 lack-
ing the g- and/or d-domain. Live Jurkat cells ex-
pressing (A) GFP-labeled CD81 or (B) CD81-Dd
imaged at 2 Hz in Ringer solution at RT using total
internal reflection fluorescence microscopy. From
left to right, overview, magnified views from
two recordings separated by 1.5 s and overlay.
Yellow color indicates areas in which the distri-
bution pattern remains unchanged. In contrast to
CD81-Dd, CD81 domains regularly remain largely
unchanged between two or more frames. Dotted
circles indicate identical regions. (C and D)
CD81 and CD81-Dd, for comparative illustration
of the lateral dynamics, over the entire movie the
PCC between two successive images was deter-
mined, essentially representing repetitive measure-
ments between two successive frames over time.
The individual PCC values were then plotted
against the time the second image of the correlated
pair of images was recorded (plots are derived from
the cells shown in A and B). (E) Averaged traces
from cells expressing GFP-labeled CD81, CD81-
Dgd, CD81-Dg, and CD81-Dd were generated
and the average PCC over all time points was
calculated. For one experiment and condition 5–8
cells were averaged and normalized to control.
Values are given as means 5 SE (n ¼ 4). To see
this figure in color, go online.
106 Homsi et al.diminished (0.35; Fig. S2) but also dependent on the pres-
ence of the d-domain (Fig. 5). Considering that the overlap
between CD81 and EWI-2 (0.53; Fig. S2) was higher than
that between CD81 and CD9, the strength of interactions
found by immunoprecipitation after cell lysis (primary and
secondary interactions, see above) is reflected in the degree
of overlap found in the microscopic assay.Biophysical Journal 107(1) 100–113EWI-2 also increased the platform size strongly (Fig. 4,D
and E), an effect that was not dependent on palmitoylation of
CD81 (Fig. 4 D). Although a diameter of 560 nm for CD81
domains (Fig. 4 E; correction for the blurring effect would
reduce this value only by ~10%) is clearly above the resolu-
tion limit, the size of CD81-Dd clusters is possibly limited by
diffraction and may represent an upper estimate. However,
FIGURE 4 For large TEMs the d-domain is required. (A and B) Membrane sheets from Jurkat cells co-overexpressing the CD81 interaction partner EWI-2
(RFP-labeled) together with GFP-labeled CD81 (A) or CD81-Dd (B). Lower panels show magnified views and overlays from the marked regions in the upper
panels. Upon overexpression of CD81-Dd-GFP, the EWI-2-RFP signal tended to show a less clustered pattern. Dotted circles indicate identical pixel loca-
tions. (C) Strong overlap between EWI-2 and the clusters in the green channel required the CD81 d-domain. Overlap was quantified by the PCC. Values are
given as means5 SE (n¼ 3–5 independent experiments and for each experiment values from 5 to 20 membrane sheets were averaged and normalized to the
respective control). (D) Cells expressing CD81-GFP or CD81-C/A-GFP without (black bars) or with (gray bars) cotransfected EWI-2-RFP. Autocorrelation
analysis (see Fig. S9 for method evaluation) of the green channel shows that EWI-2 increases the size of both CD81 and the palmitoylation deficient mutant.
Values are given as means 5 SE (n ¼ 3 independent experiments and for each experiment values from 7 to 8 membrane sheets were averaged). (E)
Coexpression of EWI-2-RFP and CD81-GFP or CD81-Dd-GFP. CD81 forms about threefold larger domains (referring to area and assuming circular shape)
when compared to CD81-Dd domains. Values are given as means5 SE (n¼ 3 independent experiments and for each experiments values from 7 to 11 mem-
brane sheets were averaged). Please note that the condition CD81-GFP/EWI-2-RFP was performed in D as well as in E, yielding a smaller effect in D, which
we explain that here we had 38% of very low EWI-2 expressing cells compared to 22% in E. To see this figure in color, go online.
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size at least by a factor of 3 (Fig. 4 E). In contrast, CD81-Dd
clusters overlapped less with EWI-2 and remained close
to diffraction-limited size (Fig. 4 E). These findings show
that CD81 and EWI-2 interact with each other and that, as
a consequence, the increase in primary complexes leads to
larger tetraspanin platforms. This is in line with a recent
report showing that EWI-2wint (EWI-2 without its N-termi-
nus, a slightly shorter cleavage product from EWI-2 (50))
decreases CD81mobility in the cell membrane and increases
the fraction of confined molecules (51). The observation that
CD81-Dd clusters failed to incorporate EWI-2 might be
explained by the putatively diminished stabilizing effect of
the large extracellular loop on the interaction with EWI-2,though interactions still should be mediated via the TMs
of both CD81 and EWI-2 (49). In contrast to Jurkat T cells,
elevation of EWI-2 in HepG2 cells did not produce larger
CD81 domains (Fig. S10). This suggests that an increase of
primary complexes promotes platform growth (in Jurkat
T cells) but per se is not sufficient for the coalescence of pri-
mary complexes into webs.
CD81 acts as a coreceptor during the entry of a variety
of pathogens into different cell types. Hence, we tested
whether the function of the d-domain, or in other words
the formation of large CD81 platforms, is also relevant
for pathogen induced endocytosis. Using pseudovirions
(PsVs) from HPV type 16, it has been shown that TEMs
are involved in HPV endocytosis and infection (16,52)Biophysical Journal 107(1) 100–113
FIGURE 5 Colocalization of CD81 and CD9.
(A) Membrane sheet from a Jurkat T cells co-over-
expressing CD81-GFP and CD9-RFP. The upper
panel shows the fluorescent protein-tagged con-
structs, the lower panel a TMA-DPH membrane
staining and an overlay. (B) Overlap was analyzed
as described in Fig. 2. Values are given as means5
SE (n ¼ 3 independent experiments; for each
experiment values from 13 to 20 membrane sheets
were averaged and the mean of CD81-Dd was
normalized to control). To see this figure in color,
go online.
108 Homsi et al.and we tested whether our CD81-GFP platforms are also
capable of mediating PsV uptake. As shown in Fig. 6,
PsVs readily triggered the formation of membrane sheet-
associated endosomes that overlap with CD81 platforms,
whereas in the absence of the d-domain hardly any PsV-trig-
gered endocytosis was detected. At sites of endocytosis, we
frequently observed patching of CD81, but not of CD81-Dd.
Such CD81 accumulation sites, overlapping with immu-
nostained PsV particles, were also observed on intact cells
with confocal microscopy (Fig. S11). These observations
are similar to a recent study showing that a hepatitis C viral
particle engaged CD81-GFP before internalization (53).
This indicates that CD81-Dd clusters are incapable of
acting as sites at which endocytosis of PsV is triggered
and that the d-domain is essential for CD81 integration
into platforms functioning in pathogen entry.DISCUSSION
CD81-enriched membrane domains
Our data show that over a wide concentration range CD81 is
enriched in domains. Though we cannot exclude that some
CD81-enriched domains contain exclusively CD81 or CD81
together with non-TEM components, several arguments
indicate that in particular the large molecular CD81 plat-
forms represent bona fide TEMs. First, the primary partner
EWI-2 is recruited into the CD81 domains increasing their
size. Second, the tetraspanin CD9, known to be coenriched
with CD81 in TEMs, also overlaps with CD81 domains.
Third, CD81 domains are platforms at which PsV-triggered
endocytosis occurs. Fourth, the lateral mobility of CD81 do-
mains is much lower when compared to non-TEM CD81-Dd
clusters that do not overlap with EWI-2.
All these findings have been obtained with fluorescent
protein-labeled CD81 and are in line with data from previ-
ous reports on immunoprecipitation experiments, indirectly
indicating that fluorescent protein tagging does not seriously
alter the behavior of CD81. This view is also supported byBiophysical Journal 107(1) 100–113our immunoprecipitation experiment verifying that CD81-
GFP still binds to endogenous CD81. In addition, we find
CD81-GFP to be coenriched with endogenous CD81 (for
earlier reports using FP tagged CD81 also see (43,53)).Role of CD81 TEMs in pathogen entry
and targeting strategies
A number of studies have documented that the CD81 mole-
cule plays a key role as an entry factor for pathogens
(19,20). The mechanisms apparently vary as in the case of
HCV, it is questionable whether association of CD81 with
TEMs is truly essential for the early steps of HCV entry
(51,54), whereas for other pathogens, such as Plasmodium,
association with TEMs is a prerequisite (55). As demon-
strated for HPV, virus/TEM association mediates endocy-
tosis during which tetraspanins and viral particles are
cointernalized into endosomes (52,56). Our study shows
that HPV pseudovirions trigger endocytosis of CD81 mole-
cules organized into platforms and that the formation of
functional platforms requires the d-domain.
One strategy for interfering with pathogen entry employs
antibodies directed against CD81/the large extracellular
loop of CD81 (14,16,57). Our findings suggest that it would
be sufficient to interfere with a much smaller binding inter-
face (the d-domain is composed of only 11 aa), possibly
using an aptamer that would be much cheaper to produce
and capable of inhibiting proper CD81 platform formation,
thereby preventing viral entry.Mechanisms of CD81 web formation
and stabilization
Tetraspanins participate in different categories of inter-
actions (5) that have been classified according to their
resistance to detergents. The direct, first-level tetraspanin-
partner interactions (22) survive harsh solubilization con-
ditions and are supposed to be the most stable ones, whereas
FIGURE 6 Virus-triggered endocytosis requires the CD81
d-domain. (A–C) Jukat cells expressing either CD81-GFP (A)
or CD81-Dd-GFP (B) were incubated in the presence of a fluid
phase marker (20 mM sulforhodamine) for 10 min at 37C with
(A and B; PsV) or without (control) HPV pseudovirions. Cells
were then adsorbed onto coverslips at 37C for 20 min, soni-
cated for the production of membrane sheets, fixed, washed,
and images were taken in the green channel (CD81-GFP or
CD81-Dd-GFP), red channel (shows internalized fluid phase
marker; red spots indicate sealed organelles associated with
the plasma membrane), and blue channel (membrane, staining
by the lipophilic dye TMA-DPH). As shown in (A), pseudovi-
rions changed the pattern of CD81 domain distribution, leading
to local accumulation of domains that often overlap with an en-
dosome. At the site of endosome formation, the accumulation
of plasma membrane was also detected in the TMA-DPH chan-
nel (see bright spots; dotted circles indicate identical pixel loca-
tions). (B) The pattern of CD81-Dd-GFP is unaffected by PsVs
and less endocytic organelles are observed. Squares in the upper
panels indicate regions magnified and overlaid in the lower
panels. (C) Quantification of endosomes per membrane sheet.
Values are given as mean 5 SE (n ¼ 3 independent experi-
ments; for one experiment 5 membrane sheets were analyzed).
To see this figure in color, go online.
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110 Homsi et al.tetraspanin-tetraspanin contacts are second-level interac-
tions and are only preserved using milder detergents (1,22).
In some cases, the classification level 1 has also been used
to refer to direct interactions (also including direct tetraspa-
nin-tetraspanin interactions that are disrupted by strong de-
tergents), whereas level 2 refers to secondary interactions
via palmitate residues (3). In any case, the tetraspanin-part-
ner pair model confers the interaction between CD81 and
EWI-2 a pivotal role in the organization of TEMs. In addi-
tion, TEMs and microdomains in general are assumed to be
the result of a developing network of interactions, suggest-
ing that in a snapshot of the TEM, more or less every mole-
cule has established direct contact to at least one other
molecule and in a sense a TEM constitutes one large supra-
molecular complex.
In two cell types, we found that the d-domain is required
for CD81 segregation into CD81 rich clusters. Such clusters,
but not those formed by CD81-Dd, are capable of growing
larger in the presence of EWI-2, but only in Jurkat T cells.
The data confirm that the CD81/EWI-2 pair interaction
plays a central role, albeit the primary complex per se is
not sufficient. Additional interactions are required for the
development of large TEMs, putatively involving also a
CD81 dimerization step, as suggested by the decreased asso-
ciation of CD81 with CD81-Dd in the immunoprecipitation
experiments.
In the absence of weak hydrophobic interactions, for
instance upon deletion of the a- and b-helices (required
for CD81 dimerization via a hydrophobic interface) or
upon removal of palmitoylation sites, only small effects
are observed. However, as we largely analyzed the static dis-
tribution of molecules in the plasma membrane, we cannot
exclude that other regions of the LEL or palmitoylation
play a more prominent role upstream of trafficking, e.g.,
in the endoplasmic reticulum or the Golgi-complex or that
the mean residence time of CD81 in TEMs is reduced in
their absence. Regarding palmitoylation, as pointed out
by (1), palmitate moieties are dispensable for interactions
between tetraspanins aside from stabilizing them, in line
with the observation that depalmitoylation of CD9 slightly
increases the diffusion coefficient by ~20% and mildly re-
duces the fraction of confined molecules by ~10% (46).
In any case, we conclude that the d-domain is essential
for formation of CD81 clusters (as well as for colocalization
of CD9 and CD81 (see Fig. 5) and EWI-2 and CD81 (see
Fig. 4)), which serve as a starting point for the development
of large TEMs, and thereby plays an essential role in regu-
lating tetraspanin web dynamics.
Structural comparison of tetraspanins revealed that the
variable domain of the LEL, inserted within the conserved
domain and containing only a few conserved residues, dif-
fers between tetraspanins in length and secondary structure
(58). If the d-domains in other tetraspanins were found to
be equally essential for the formation of large TEMs (with
other binding partners), it would be tempting to speculateBiophysical Journal 107(1) 100–113that this region defines in which biological process the
respective tetraspanin acts via its ability to generate large
TEMs. This view is in line with previous studies showing
that CD9, carrying the LEL of CD81, is capable of acting
like CD81 in viral entry (59).
Assuming a sequence of interactions, by which a supra-
molecular TEM is generated, is an explanation complying
with the previous expectation about how most microdo-
mains in general, or in this case, TEMs do form. However,
as will be discussed below, some findings may point to an
alternative explanation based on cluster phases.Cluster phases as alternative explanation?
For many years, the enrichment and sorting of proteins in
microdomains has been a major biological issue, yet it
remains poorly understood. Originally, the phenomenon
was explained by, e.g., picket fences capturing proteins in
diffusion compartments (60) or by enrichment of certain
proteins in lipid rafts generated through clustering of sphin-
golipids and cholesterol in the outer membrane (61,62).
However, such mechanisms cannot explain the high degree
of micropatterning observed, for instance, when two iso-
forms of a protein segregate into separate domains despite
their high structural similarity (63–65). These observations,
including findings made in this study, indicate that a more
fundamental explanation, based on gain in free energy, plays
a major role in micropatterning mechanisms, similar to the
transition during condensed phase formation in solution.
Cluster phases arise from the competition between mod-
erate short-range attractions—a few times the thermal
energy kBT—and longer range repulsion—in the range of,
or lower than the thermal energy (66). Accordingly, small
modulations of the attractive forces lead to the segrega-
tion (or sorting) of different proteins into specialized,
distinct clusters, because the subsequent cost in entropy is
counterbalanced by the gain of stabilizing interactions
(66). Fig. S12 illustrates and explains the model in greater
detail. In contrast to the classical image outlined previously,
cluster phases rely on a dynamical point of view. For
example, the interaction strength of the small d-domain
can be only moderate, because it involves few residue-resi-
due interactions. Such moderate attractions are unlikely to
be stable on long timescales, but metastable, and thus to
break through thermal agitation, explaining why in cluster
phases most molecules are free to diffuse inside clusters
and even, from time to time, to escape clusters and to diffuse
freely in the membrane before being captured again by
another cluster.
In this view, d-domains are involved in interactions of
higher energetic affinity between CD81 and its partners
(see Fig. S12), in addition to less specific forces. The low
level of colocalization observed between CD81-Dd and
EWI-2 (Fig. 4 C) is then the result of a weakened interaction
between CD81 and EWI-2, in line with previous reports that
Role of the CD81 d-Domain in Molecular Web Formation 111the LEL is supporting (but not essential) for CD81-EWI-2
interactions (49). Pushing this hypothesis further, modula-
tion of the small d-domains between different tetraspanins
would promote their targeting to different cluster types to
perform specific biological functions. Conversely, in the
absence of d-domains, a different pattern of preferential in-
teractions energies (as a result of interacting with other part-
ners) generates different clusters (in our study, they are more
unstable and not able to grow). The colocalization of CD81
and CD9 appears to follow the same logic. Apart from the
findings in this study, other examples document that small
modifications of a protein domain cause missorting or
even declustering see, e.g. (67), which cannot be explained
exclusively by weakening specifically one direct primary
interaction, because that should decrease only the number
of binary complexes but not their capability to coalesce
into clusters.
The cluster phase model theoretically predicts (68) that
increasing the concentration of a cluster component only
marginally changes cluster size but significantly increases
the number of clusters. In agreement with this prediction,
we find more and apparently not larger clusters upon
CD81 increase (see Fig. 1), a typical cluster phase behavior
also observed previously, e.g., in (69). By contrast, the clus-
ter phase model predicts growth of clusters when increasing
the attractive forces, e.g., here, by overexpression of EWI-2
or by soluble interaction partners on the surface of viruses.
These arguments support the proposition that CD81 and
its partners form cluster phases driven by free-energy
gain, related either to weak interactions (e.g., hydrophobic
surfaces or palmitoylation) or to moderate, more specific in-
teractions involving the d-domain. Presently, this scenario
can be considered just as a conceptual framework to be
explored in the future to assess its relevance with respect
to the classical one.SUPPORTING MATERIAL
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